- The 100th procedure milestone was achieved quickly following the announcement of the first U.S. prodisc® C Vivo implantation on Sept. 7.
- The prodisc C Vivo system has been used internationally since 2009 and is one of the most frequently implanted TDR devices in the world.
- The prodisc C Vivo device incorporates prodisc CORE technology used in over 225,000 implantations worldwide.
WEST CHESTER, Pa., Oct. 27, 2022 /PRNewswire/ — Centinel Spine®, LLC, (“the Company”) a leading global medical device company addressing cervical and lumbar spinal disease through anterior surgical access, today announced the 100th completed procedure in the United States with its prodisc® C Vivo Cervical Total Disc Replacement (TDR) product. This milestone was achieved quickly after the Company announced the first U.S. implantation of the prodisc C Vivo on Sept. 7. During this short period, the Company has trained over 70 surgeons and more than 30 new surgeons are now using the system…